Literature DB >> 16510257

Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory.

N Faisant1, J Akiki, F Siepmann, J P Benoit, J Siepmann.   

Abstract

The major objectives of the present study were: (i) to prepare 5-fluorouracil (5-FU)-loaded, poly(lactic-co-glycolic acid) (PLGA)-based microparticles, which can be used for the treatment of brain tumors, (ii) to study the effects of the type of release medium on the resulting drug release kinetics, and (iii) to get further insight into the underlying drug release mechanisms. Spherical microparticles were prepared by a solvent extraction method and characterized using different techniques, including size exclusion chromatography (SEC), differential scanning calorimetry (DSC), scanning electron microscopy (SEM) and particle size analysis before and upon exposure to various release media. Interestingly, very different drug release patterns (including mono-, bi- and tri-phasic ones) were observed, depending on the pH, osmolarity and temperature of the release medium. An adequate mathematical theory was used to quantitatively describe the experimentally measured 5-FU release patterns. The model considers the limited solubility of the drug, polymer degradation as well as drug diffusion and allowed to determine system and release medium specific parameters, such as the diffusion coefficient of the drug. In particular, the pH and temperature of the release medium were found to be of major importance for the resulting release patterns. Based on the obtained knowledge the selection of an appropriate release medium for in vitro tests simulating in vivo conditions can be facilitated, and "stress tests" can be developed allowing to get rapid feedback on the release characteristics of a specific batch.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16510257     DOI: 10.1016/j.ijpharm.2005.07.030

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  24 in total

1.  Accelerated in vitro release testing of implantable PLGA microsphere/PVA hydrogel composite coatings.

Authors:  Jie Shen; Diane J Burgess
Journal:  Int J Pharm       Date:  2011-10-13       Impact factor: 5.875

2.  Expansion of microvascular networks in vivo by phthalimide neovascular factor 1 (PNF1).

Authors:  Kristen A Wieghaus; Meghan M Nickerson; Caren E Petrie Aronin; Lauren S Sefcik; Richard J Price; Mikell A Paige; Milton L Brown; Edward A Botchwey
Journal:  Biomaterials       Date:  2008-09-18       Impact factor: 12.479

3.  Kinetically controlled cellular interactions of polymer-polymer and polymer-liposome nanohybrid systems.

Authors:  Suhair Sunoqrot; Jin Woo Bae; Su-Eon Jin; Ryan M Pearson; Ying Liu; Seungpyo Hong
Journal:  Bioconjug Chem       Date:  2011-02-23       Impact factor: 4.774

4.  Preparation of TPP-crosslinked chitosan microparticles by spray drying for the controlled delivery of progesterone intended for estrus synchronization in cattle.

Authors:  Ignacio M Helbling; Carlos A Busatto; Silvana A Fioramonti; Juan I Pesoa; Liliana Santiago; Diana A Estenoz; Julio A Luna
Journal:  Pharm Res       Date:  2018-02-20       Impact factor: 4.200

5.  Drug release kinetics, cell uptake, and tumor toxicity of hybrid VVVVVVKK peptide-assembled polylactide nanoparticles.

Authors:  Esmaiel Jabbari; Xiaoming Yang; Seyedsina Moeinzadeh; Xuezhong He
Journal:  Eur J Pharm Biopharm       Date:  2012-12-27       Impact factor: 5.571

Review 6.  How does the pathophysiological context influence delivery of bone growth factors?

Authors:  Xiaohua Yu; Darilis Suárez-González; Andrew S Khalil; William L Murphy
Journal:  Adv Drug Deliv Rev       Date:  2014-10-17       Impact factor: 15.470

Review 7.  Accelerated in-vitro release testing methods for extended-release parenteral dosage forms.

Authors:  Jie Shen; Diane J Burgess
Journal:  J Pharm Pharmacol       Date:  2012-03-08       Impact factor: 3.765

8.  Sustained release of matrix metalloproteinase-3 to trabecular meshwork cells using biodegradable PLGA microparticles.

Authors:  Sanja Turturro; Suhair Sunoqrot; Hongyu Ying; Seungpyo Hong; Beatrice Y J T Yue
Journal:  Mol Pharm       Date:  2013-07-18       Impact factor: 4.939

9.  5-Fluorouracil encapsulated HA/PLGA composite microspheres for cancer therapy.

Authors:  Yuting Lin; Yan Li; Chui Ping Ooi
Journal:  J Mater Sci Mater Med       Date:  2012-07-29       Impact factor: 3.896

10.  Sustained release of sphingosine 1-phosphate for therapeutic arteriogenesis and bone tissue engineering.

Authors:  Lauren S Sefcik; Caren E Petrie Aronin; Kristen A Wieghaus; Edward A Botchwey
Journal:  Biomaterials       Date:  2008-04-11       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.